Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

15. Novembre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 2006


	Articles 1 - 20 / 40101

	Delaying thoracic radiotherapy does not compromise overall survival in extensive-stage small cell lung cancer after first-line systemic treatment: a multicenter real-world cohort study. Clin Transl Radiat Oncol Zheng L, Le X, Huang Y, Cheng Q, Ying Z, Ding Y, Ye R, Zhang F, Chen H, Wang E, Zhu L, Yan R, You G, Wang S, Sun X, Wang Y, Fang J, Xu Y, Zhou Z. PMID: 43032292 [PubMed]
	Complement in cancer-associated fibroblasts: sources, regulation and context dependence. Front Immunol Lei K. PMID: 43032046 [PubMed - indexed for MEDLINE]
	Periostin within the tumor microenvironment: molecular insights and immunomodulatory roles in cancer. Front Immunol Zhao Y, Yu Y, Li S, Xu L, Chen W, Lv J. PMID: 43032026 [PubMed - indexed for MEDLINE]
	Clinical and CT body-composition model for major pathological response to neoadjuvant tislelizumab, albumin-bound paclitaxel, and nedaplatin in esophageal squamous cell carcinoma. Front Oncol Xu H, Zheng W, Chen S, Wu S. PMID: 43031628 [PubMed]
	Artificial Intelligence-Assisted Endoscopic Assessment of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer: From Residual Disease Detection to Active Surveillance and Surgical Decision-Making. Diagnostics (Basel) Tao Y, Zhao X, Zhao Y, Wang N, Wang M, Yao F. PMID: 43028469 [PubMed]
	Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990-2023: Evidence from the Global Burden of Disease Study 2023. Cancers (Basel) Guo L, Zhu C, Yuan J, Cai L, Luan H, Chen H, Zheng Y, Liu Y. PMID: 43026856 [PubMed]
	A Literature-Derived Muscle Wasting-Related Prognostic Signature Identifies ZBTB7C as a Candidate Associated with Tumor-Related Skeletal Muscle Alterations in Esophageal Cancer. Cancers (Basel) Li Y, Xie C, Chen R, Ming Z, Huang H, Ding S. PMID: 43026800 [PubMed]
	Artificial Intelligence in Thoracic Surgical Oncology: Technical Foundations and Applications in Lung and Esophageal Cancer Surgery. Cancers (Basel) Cassidy R, Razzaq S, Howell A, Leiva-Juarez M, Schumacher L. PMID: 43026760 [PubMed]
	First-line treatment of gastric cancer: Five trials to watch. Med Narita Y, Muro K. PMID: 43025398 [PubMed - indexed for MEDLINE]
	A visual molecular classifier based on Bsu-T7 weighted linear isothermal amplification for precision cancer diagnosis. Biosens Bioelectron Lin Y, Li Y, Cui C, Geng A, Sun Y, Zhu Q, Zhang Z, Su G, Yu Y. PMID: 43025095 [PubMed - as supplied by publisher]
	Association of sex and age on outcomes of maintenance treatment in patiâ€‹ents with advanced esophagogastric adenocarcinoma: an exploratory analysis of the randomized AIO-YMO-0111-MATEO trial. J Cancer Res Clin Oncol Stocker G, Stelmach R, Lorenzen S, Ettrich T, Knödler M, Longo F, Chibaudel B, Greil R, Perwög M, Larcher-Steiner J, Held S, Lordick F, Haag GM. PMID: 43024019 [PubMed - indexed for MEDLINE]
	Multi-omics and pharmacological analyses identify DDX60 as a candidate EGCG-engaged target in esophageal squamous cell carcinoma. Eur J Pharmacol Zhu H, Ainiwa A, Zhang YH, Lv GH, Zhao LT, Abuduwaili A, Chen HY, Jing XL, Ma RY. PMID: 43020306 [PubMed - as supplied by publisher]
	Izalontamab Brengitecan in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: The PANKU-Esophagus01 Randomized Clinical Trial. JAMA Lu Z, Huang Z, Meng X, Fan Y, Wu T, Pang Q, Wang F, Zhang Y, Gao S, Liu T, Zhou J, Fang Y, Li N, Li W, Cao G, Zhou S, Li N, Ye F, Ji Y, Zhang J, Cai X, Xiong J, Zhang M, Wan L, Gu Y, Luo H, Zhang X, Qu J, Yang W, Cao J, Zhu X, Chen J, Yi T, Gao Y, Huang J, Liu Z, Wang J, Ma F, Luo Y, Ma X, Fu J, Ding S, Liu Y, Xiao S, Zhu H, Zhu Y, Shen L, PANKU-Esophagus01 Investigators. PMID: 43018949 [PubMed - as supplied by publisher]
	Acute Hematemesis Leading to the Incidental Diagnosis of Esophageal Squamous Cell Carcinoma in an Adolescent: First Case Report From Pakistan. Clin Case Rep Hameed M, Mazhar Z, Abedeen ZU, Sohaib HU, Bashir H, Zainab HH, Ghani MZ, Rehman AU. PMID: 43016893 [PubMed]
	Association of trilaciclib use with hematologic outcomes during perioperative immunochemotherapy in resectable esophageal squamous cell carcinoma: a prospective observational cohort study. Front Pharmacol He C, Lin X, Xu H, Lin J, Li P, Wang W, Chen B, Lin R, Zhang S, Li H, Zhang X, Li Y, Huang Z, Xie R, Chen Z, Wu J, Huang C, Guo R, Gao H, Xie Z, Wu H. PMID: 43016856 [PubMed]
	Multi-omics integration identifies serum FTL as a novel diagnostic biomarker for esophageal squamous cell carcinoma. Front Immunol Chen WZ, Chen SL, Han RK, Wu XR, Liang JC, Wu MT, Sun GY, Chen H. PMID: 43016823 [PubMed - indexed for MEDLINE]
	Barriers and facilitators for implementing active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer in Dutch hospitals: a qualitative study. BMJ Open Gangaram Panday SSG, Kim Y, Ista E, Mostert B, Kranenburg L, van Lanschot JJB, Spaander MCW, Dekker JWT, Heisterkamp J, Nieuwenhuijzen GAP, Pierie JP, Rosman C, van Sandick JW, Lagarde SM, Wijnhoven BPL, SANO Study Group. PMID: 43015016 [PubMed - in process]
	Imaging-Based AI for Predicting Pathological Complete Response in Esophageal Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis. J Med Internet Res Li Z, Gao X, Zhou J, Wang L, Ren F. PMID: 43013774 [PubMed - indexed for MEDLINE]
	Pre-treatment serum bicarbonate predicts survival in patients with locally advanced esophageal squamous cell carcinoma undergoing definitive radiotherapy: a retrospective propensity score matching study. BMC Cancer Ji H, Zhang P, Wang Y, Su Y, Si H, Jia Y, Qiao X, Zhou Z. PMID: 43009855 [PubMed - indexed for MEDLINE]
	High tissue factor (CD142) expression identifies a poor-prognosis subgroup of esophageal and esophagogastric junction adenocarcinoma. BMC Cancer Bedau T, Zander T, Schlößer H, Büttner R, Bruns C, Quaas A. PMID: 43009849 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 40101

Page 1 de 2006



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité